Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Nov;53(11):846–850. doi: 10.1136/jcp.53.11.846

What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?

R Arisio 1, A Sapino 1, P Cassoni 1, G Accinelli 1, M Cuccorese 1, M Mano 1, G Bussolati 1
PMCID: PMC1731116  PMID: 11127267

Abstract

Aims—To evaluate which pathological and clinical parameters modify the relation between tumour size and lymph node metastases in invasive breast carcinomas < 20 mm.

Methods—In a retrospective study, 1075 patients with pT1 invasive breast carcinoma and with known nodal status were analysed. The size of the infiltrating tumour was microscopically evaluated, and the in situ component was not considered. The additional pathological parameters considered were: tumour grade, peritumoral vascular invasion, multicentricity, and angiogenesis. The immunophenotype of the tumour was determined as: the expression of oestrogen (ER) and progesterone (PR) receptors, p53, and c-erbB2. The patients were grouped by age as follows: < 50, 51–70, and > 70 years old.

Results—Three hundred and seventy four patients (34.8%) were node positive. Univariate analysis showed that nodal positivity was significantly correlated with large tumour size (> 10 mm), vascular invasion, grade 2–3, multicentricity, and high angiogenesis (> 100 microvessels/x20 high power frame). No significant correlation was found between nodal positivity and ER, PR, p53, or c-erbB2 status. Interestingly, the association with in situ carcinoma was correlated with lower nodal positivity in tumours presenting equally sized infiltrating components. Age was an independent variable and significantly modified the risk of nodal positivity in tumours < 1 cm. In fact, in patients under 51 years of age, the proportion of nodal positivity in pT1a tumours was sevenfold higher than in older patients. In patients from 51 to 70 years old, nodal positivity correlated with tumour size, and multicentricity was an additional risk factor.

Conclusions—These data suggest that, together with tumour size, the presence of in situ carcinoma, and vascular invasion, age is one of the most important predictors of metastatic diffusion in breast carcinomas.

Key Words: breast cancer • pT1 • node status

Full Text

The Full Text of this article is available as a PDF (118.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barth A., Craig P. H., Silverstein M. J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997 May 15;79(10):1918–1922. [PubMed] [Google Scholar]
  3. Chontos A. J., Maher D. P., Ratzer E. R., Fenoglio M. E. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg. 1997 May;184(5):493–498. [PubMed] [Google Scholar]
  4. Dixon M. Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials. BMJ. 1998 Aug 1;317(7154):295–296. doi: 10.1136/bmj.317.7154.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elston C. W., Ellis I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403–410. doi: 10.1111/j.1365-2559.1991.tb00229.x. [DOI] [PubMed] [Google Scholar]
  6. Goldhirsch A., Glick J. H., Gelber R. D., Senn H. J. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst. 1998 Nov 4;90(21):1601–1608. doi: 10.1093/jnci/90.21.1601. [DOI] [PubMed] [Google Scholar]
  7. Greco M., Agresti R., Raselli R., Giovanazzi R., Veronesi U. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Anticancer Res. 1996 Nov-Dec;16(6C):3913–3917. [PubMed] [Google Scholar]
  8. Hansen S., Grabau D. A., Sørensen F. B., Bak M., Vach W., Rose C. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer. 2000 Jan;82(2):339–347. doi: 10.1054/bjoc.1999.0924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hébert-Croteau N., Brisson J., Latreille J., Blanchette C., Deschênes L. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999 Mar 1;85(5):1104–1113. [PubMed] [Google Scholar]
  10. Maibenco D. C., Weiss L. K., Pawlish K. S., Severson R. K. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer. 1999 Apr 1;85(7):1530–1536. [PubMed] [Google Scholar]
  11. Robinson D. S., Senofsky G. M., Ketcham A. S. Role and extent of lymphadenectomy for early breast cancer. Semin Surg Oncol. 1992 Mar-Apr;8(2):78–82. doi: 10.1002/ssu.2980080206. [DOI] [PubMed] [Google Scholar]
  12. Seidman J. D., Schnaper L. A., Aisner S. C. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer. 1995 Jan 1;75(1):65–71. doi: 10.1002/1097-0142(19950101)75:1<65::aid-cncr2820750112>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  13. Silverstein M. J., Gierson E. D., Waisman J. R., Senofsky G. M., Colburn W. J., Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer. 1994 Feb 1;73(3):664–667. doi: 10.1002/1097-0142(19940201)73:3<664::aid-cncr2820730326>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  14. Silverstein M. J. Recent advances. Diagnosis and treatment of early breast cancer. BMJ. 1997 Jun 14;314(7096):1736–1739. doi: 10.1136/bmj.314.7096.1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Van Diest P. J., Torrenga H., Borgstein P. J., Pijpers R., Bleichrodt R. P., Rahusen F. D., Meijer S. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. 1999 Jul;35(1):14–18. doi: 10.1046/j.1365-2559.1999.00667.x. [DOI] [PubMed] [Google Scholar]
  16. van Diest P. J., van Dam P., Henzen-Logmans S. C., Berns E., van der Burg M. E., Green J., Vergote I. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol. 1997 Oct;50(10):801–804. doi: 10.1136/jcp.50.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES